Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events
Global healthcare business of Fresenius SE supplying generic injectable pharmaceuticals, IV drugs, clinical nutrition, biosimilars and infusion technologies to hospitals and clinics worldwide.
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events